BIOMAT Database Logo BIOMAT Database Logo

Targeting FHL2 for EGFRvIII-positive glioblastoma. 2018

Lili Sun, and Qing Lan, and Ming Li
Ming Li: The Experimental Center, Department of Neurosurgery, The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China.

UI MeSH Term Description Entries

Related Publications

Lili Sun, and Qing Lan, and Ming Li
Targeting EGFRvIII for glioblastoma multiforme.
September 2017, Cancer letters,
Lili Sun, and Qing Lan, and Ming Li
G2 checkpoint targeting via Wee1 inhibition radiosensitizes EGFRvIII-positive glioblastoma cells.
January 2023, Radiation oncology (London, England),
Lili Sun, and Qing Lan, and Ming Li
Current Therapeutic Advances Targeting EGFR and EGFRvIII in Glioblastoma.
January 2015, Frontiers in oncology,
Lili Sun, and Qing Lan, and Ming Li
[Targeting EGFRvIII for treatment of glioblastoma: From molecular mechanisms to clinical strategies].
November 2019, Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences,
Lili Sun, and Qing Lan, and Ming Li
Metabolic targeting of EGFRvIII/PDK1 axis in temozolomide resistant glioblastoma.
May 2017, Oncotarget,
Lili Sun, and Qing Lan, and Ming Li
Selective Targeting of Glioblastoma with EGFRvIII/EGFR Bitargeted Chimeric Antigen Receptor T Cell.
November 2018, Cancer immunology research,
Lili Sun, and Qing Lan, and Ming Li
Engineered superparamagnetic iron oxide nanoparticles (SPIONs) for dual-modality imaging of intracranial glioblastoma via EGFRvIII targeting.
January 2019, Beilstein journal of nanotechnology,
Lili Sun, and Qing Lan, and Ming Li
Efficacy of osimertinib against EGFRvIII+ glioblastoma.
June 2020, Oncotarget,
Lili Sun, and Qing Lan, and Ming Li
The EGFRvIII variant in glioblastoma multiforme.
June 2009, Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia,
Lili Sun, and Qing Lan, and Ming Li
Targeting immunoliposomes to EGFR-positive glioblastoma.
February 2022, ESMO open,
Copied contents to your clipboard!